Donald Trump’s tariff tussle: Duties on Indian pharma would be ‘counterproductive’; America may take at least 3 years to match India’s scale, says Pharmexcil

US President Donald Trump imposed an additional 25% tariff on Indian imports on the top of an already existing 25% duty, pushing the total to 50%. These high tariffs, announced on August 6, would take effect from August 27.The pharmaceutical sector, however, received a temporary exemption from the tariff hike, highlighting India’s crucial role in…

Read More

Refinery crisis: EU sanctions hit Nayara logistics as shipping lines pull back; seeks government help

Fuel supply from Nayara Energy’s Vadinar refinery has been severely disrupted after shipowners, wary of European Union sanctions, stopped lifting products from the facility, forcing the Rosneft-backed company to seek government help to arrange alternate shipping support.Nayara, which used vessels to supply petrol and diesel to consumption hubs along India’s west coast and as far…

Read More

India-US tariff tussle: CTI suggests exploring alternative markets; ‘traders are in a dilemma’

The Chamber of Trade and Industry (CTI) has voiced concerns over the US’s latest decision to impose an additional 25% tariff on Indian goods, taking the total duty to 50%. The body warned of serious consequences for India’s export driven businesses.CTI chairman Brijesh Goyal wrote to PM Narendra Modi, calling for immediate and strategic action,…

Read More

Trade war: US tariffs on India may hurt manufacturing, labour-intensive sectors; experts warn of wider economic impact

The recent hike in US tariffs on Indian imports could severely impact labour-intensive and manufacturing sectors in India, posing a risk to the country’s economic growth if the 50% duty continues, experts warned.They said the steep tariffs not only risk slowing exports and investment but also add pressure on the rupee, raising concerns for the…

Read More